Can a woman with a prior history of blood clot take Plan B (levonorgestrel) emergency contraception?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, a woman with a prior history of blood clot can safely take Plan B (levonorgestrel) emergency contraception.

Plan B is a progestin-only emergency contraceptive that does not increase thrombotic risk and is safe for women with a history of venous thromboembolism (VTE). This is a critical distinction from combined hormonal contraceptives (which contain estrogen) that are contraindicated in women with prior blood clots.

Key Evidence Supporting Safety

Progestin-Only Formulations Do Not Increase Clot Risk

The French Society of Endocrinology guidelines specifically note that levonorgestrel-based emergency contraception showed no excess risk of venous thromboembolism 1. The evidence demonstrates:

  • No significant increase in VTE risk with levonorgestrel at emergency contraceptive doses (OR: 1.45 [95% CI: 0.92-2.26] for progestin-only methods overall, with no excess risk specifically noted for levonorgestrel 30 mg) 1
  • Progestins at these doses do not affect hemostatic parameters 1

No Effect on Clotting Factors

A dedicated study examining clotting factors after emergency contraception found no obvious effect on Factor VII or antithrombin III levels after the Yuzpe regimen (which contains both estrogen and progestin). The study concluded that the short-lived dosage should not be automatically dismissed even in women with previous thromboembolic disease 2.

Broader Safety Profile

Research confirms that progestin-only contraceptives are generally considered safe for women at high risk for thrombosis, including those with a history of VTE 3. A systematic review found that most adverse reactions to levonorgestrel emergency contraception were common and not serious 4.

Critical Distinction: Emergency vs. Regular Contraception

Plan B is fundamentally different from regular hormonal contraception:

  • Single-use, short duration: Contains only 1.5 mg total levonorgestrel taken once or in two 0.75 mg doses 12 hours apart 5
  • No estrogen component: Unlike combined oral contraceptives that significantly increase VTE risk (2-4 fold), Plan B contains only progestin 1
  • Brief exposure: The hormone exposure is extremely limited compared to ongoing contraceptive use

Important Caveats

What Plan B Does NOT Do:

  • Does not protect against HIV/STIs 5
  • Not intended for routine contraceptive use 5
  • Not effective if already pregnant 5

When to Seek Medical Attention:

  • Severe lower abdominal pain 3-5 weeks after taking Plan B (to evaluate for ectopic pregnancy) 5
  • Period delayed more than one week beyond expected date 5

Practical Guidance

For a woman with prior VTE who needs emergency contraception:

  1. Plan B is safe to use - the progestin-only formulation does not increase thrombotic risk
  2. Take as soon as possible within 72 hours of unprotected intercourse for maximum efficacy 5
  3. No special monitoring required for the history of blood clot
  4. Continue anticoagulation if currently prescribed (levonorgestrel does not interact with anticoagulants) 6

The evidence is reassuring that the brief, progestin-only exposure from Plan B does not pose a thrombotic risk, even in women with previous blood clots. This is in stark contrast to estrogen-containing contraceptives, which are absolutely contraindicated in this population.

References

Research

Clotting factors after emergency contraception.

Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1993

Research

Contraceptive Management for Women Who Are at High Risk of Thrombosis.

Clinical obstetrics and gynecology, 2018

Research

Effect of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers among women with thrombophilia or previous venous thromboembolism.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.